Trial Profile

Efficacy and tolerability of mirtazapine in patients with post-myocardial infarction depression in the Myocardial Infarction and Depression-Intervention Trial (MIND-IT)

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 01 Sep 2015

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Mirtazapine (Primary) ; Citalopram
Indications Cardiovascular disorders; Depression
Focus Therapeutic Use
Acronyms MIND-IT

Most Recent Events

24 May 2012 New source identifed and integrated (ISRCTN: Current Controlled Trials record.)
01 Feb 2011 Substudy results published in the Neuropsychobiology.
05 Nov 2010 New trial record.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com